Polymyxin B
Product Images NDC 45932-0030

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 45932-0030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Aps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Polymyxin (Polymyxin Carton)

This is a drug label for Polymyxin B Sulfate used for intramuscular, intravenous, and/or intrathecal administration in hospitals. The drug may be neuro- and nephrotoxic and should be administered under constant supervision by a physician. Dosages should not exceed 25,000 units per kg per day. The drug comes in a lyophilized form and each vial contains Polymyxin B Sulfate equivalent to 500,000 polymyxin B units. The label also includes storage instructions and a warning message for healthcare professionals to read the accompanying professional information.*

FDA Label Image

Polymyxin (Polymyxin Image1)

This appears to be a chemical compound formula. It contains the names of different compounds such as Dab:PheLou, CO-DapThr Dab Dab, Polymyxin B and their respective structural formulas. The formula appears to be incomplete and is not very useful for describing the properties and uses of these compounds.*

FDA Label Image

Polymyxin (Polymyxin Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.